当前位置:首页 - 行情中心 - 爱司凯(300521) - 财务分析 - 现金流量表

爱司凯

(300521)

  

流通市值:41.29亿  总市值:41.29亿
流通股本:1.49亿   总股本:1.49亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金60,103,866.8439,558,786.41157,570,104.27138,222,778.94
  收到的税费返还4,911,041.282,994,975.5711,179,028.388,105,277.21
  收到其他与经营活动有关的现金12,874,090.1510,917,830.492,543,092.182,843,150.43
  经营活动现金流入小计77,888,998.2753,471,592.47171,292,224.83149,171,206.58
  购买商品、接受劳务支付的现金45,102,906.831,083,161.9396,759,332.2102,656,401.15
  支付给职工以及为职工支付的现金30,177,555.4818,513,171.5247,142,394.1335,807,772.22
  支付的各项税费7,516,706.453,965,683.4615,168,349.6111,307,976.38
  支付其他与经营活动有关的现金16,681,663.97,343,367.6524,542,693.1224,595,162.78
  经营活动现金流出小计99,478,832.6360,905,384.56183,612,769.06174,367,312.53
  经营活动产生的现金流量净额-21,589,834.36-7,433,792.09-12,320,544.23-25,196,105.95
二、投资活动产生的现金流量:
  收回投资收到的现金--140,000,000140,618,454.83
  取得投资收益收到的现金--618,454.83-
  处置固定资产、无形资产和其他长期资产收回的现金净额50,019.1731,858.494,508.53100,096.83
  处置子公司及其他营业单位收到的现金净额2,379,028.76---
  投资活动现金流入小计2,429,047.9331,858.4140,712,963.36140,718,551.66
  购建固定资产、无形资产和其他长期资产支付的现金11,730,745.267,027,524.244,262,494.512,535,976.32
  投资支付的现金30,000,000-100,000,000100,000,000
  投资活动现金流出小计41,730,745.267,027,524.24104,262,494.51102,535,976.32
  投资活动产生的现金流量净额-39,301,697.33-6,995,665.8436,450,468.8538,182,575.34
三、筹资活动产生的现金流量:
  吸收投资收到的现金52,005,550---
  收到其他与筹资活动有关的现金--4,990,861.11-
  筹资活动现金流入平衡项目0-0-
  筹资活动现金流入小计52,005,550-4,990,861.11-
  分配股利、利润或偿付利息支付的现金5,760,0005,760,000--
  筹资活动现金流出平衡项目00--
  筹资活动现金流出小计5,760,0005,760,000--
  筹资活动产生的现金流量净额平衡项目000-
  筹资活动产生的现金流量净额46,245,550-5,760,0004,990,861.11-
四、汇率变动对现金及现金等价物的影响220,477.35189,473.59705,514.35455,274.03
五、现金及现金等价物净增加额-14,425,504.34-19,999,984.3429,826,300.0813,441,743.42
  加:期初现金及现金等价物余额89,329,720.8489,329,720.8459,503,420.7659,503,420.76
  期末现金及现金等价物余额74,904,216.569,329,736.589,329,720.8472,945,164.18
补充资料:
  净利润-13,251,538.69--3,048,283.95-
  资产减值准备-314,393.85--4,630,279.31-
  固定资产和投资性房地产折旧7,253,239.16-14,819,914.91-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧7,253,239.16-14,819,914.91-
  无形资产摊销227,823.95-352,778.61-
  长期待摊费用摊销506,299.25-977,096.87-
  处置固定资产、无形资产和其他长期资产的损失--314,052.65-
  固定资产报废损失1,020,870.41-2,121.1-
  公允价值变动损失80,329.8-474,606.23-
  财务费用-220,477.35--696,375.46-
  投资损失2,619,774.18-3,644,550.9-
  递延所得税129,565.54-2,372,808.28-
  其中:递延所得税资产减少-234,902.7-2,682,825.53-
    递延所得税负债增加364,468.24--310,017.25-
  存货的减少-23,175,568.97--10,824,395.9-
  经营性应收项目的减少-7,031,515.11--21,098,855.77-
  经营性应付项目的增加9,217,574.79-2,383,040.45-
  其他1,348,182.53-2,636,676.16-
  现金的期末余额74,904,216.5-89,329,720.84-
  减:现金的期初余额89,329,720.84-59,503,420.76-
  现金及现金等价物的净增加额-14,425,504.34-29,826,300.08-
公告日期2025-08-292025-04-292025-04-292024-10-29
审计意见(境内)标准无保留意见
TOP↑